Your browser doesn't support javascript.
loading
Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP).
Kang, Jae Seung; Mok, Lydia; Heo, Jin Seok; Han, In Woong; Shin, Sang Hyun; Yoon, Yoo-Seok; Han, Ho-Seong; Hwang, Dae Wook; Lee, Jae Hoon; Lee, Woo Jung; Park, Sang Jae; Park, Joon Seong; Kim, Yonghoon; Lee, Huisong; Yu, Young-Dong; Yang, Jae Do; Lee, Seung Eun; Park, Il Young; Jeong, Chi-Young; Roh, Younghoon; Kim, Seong-Ryong; Moon, Ju Ik; Lee, Sang Kuon; Kim, Hee Joon; Lee, Seungyeoun; Kim, Hongbeom; Kwon, Wooil; Lim, Chang-Sup; Jang, Jin-Young; Park, Taesung.
Afiliação
  • Kang JS; Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
  • Mok L; Department of Statistics and Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, Korea.
  • Heo JS; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Han IW; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Shin SH; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Yoon YS; Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Han HS; Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Hwang DW; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee JH; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Lee WJ; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
  • Park SJ; Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea.
  • Park JS; Pancreatobiliary Cancer Clinic, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Kim Y; Department of Surgery, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
  • Lee H; Department of Surgery, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea.
  • Yu YD; Division of HBP Surgery and Liver Transplantation, Department of Surgery, Korea University College of Medicine, Seoul, Korea.
  • Yang JD; Department of Surgery, Jeonbuk National University Medical School, Jeonju, Korea.
  • Lee SE; Department of Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
  • Park IY; Department of General Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
  • Jeong CY; Department of Surgery, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea.
  • Roh Y; Department of Surgery, Dong-A University College of Medicine, Busan, Korea.
  • Kim SR; Department of Surgery, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.
  • Moon JI; Department of Surgery, Konyang University Hospital, Daejeon, Korea.
  • Lee SK; Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea.
  • Kim HJ; Department of Surgery, Chonnam National University Hospital, Gwangju, Korea.
  • Lee S; Department of Mathematics and Statistics, Sejong University, Seoul, Korea.
  • Kim H; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Kwon W; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Lim CS; Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
  • Jang JY; Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Park T; Department of Statistics and Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, Korea.
Gut Liver ; 15(6): 912-921, 2021 11 15.
Article em En | MEDLINE | ID: mdl-33941710
Background/Aims: Several prediction models for evaluating the prognosis of nonmetastatic resected pancreatic ductal adenocarcinoma (PDAC) have been developed, and their performances were reported to be superior to that of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system. We developed a prediction model to evaluate the prognosis of resected PDAC and externally validated it with data from a nationwide Korean database. Methods: Data from the Surveillance, Epidemiology and End Results (SEER) database were utilized for model development, and data from the Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP) database were used for external validation. Potential candidate variables for model development were age, sex, histologic differentiation, tumor location, adjuvant chemotherapy, and the AJCC 8th staging system T and N stages. For external validation, the concordance index (C-index) and time-dependent area under the receiver operating characteristic curve (AUC) were evaluated. Results: Between 2004 and 2016, data from 9,624 patients were utilized for model development, and data from 3,282 patients were used for external validation. In the multivariate Cox proportional hazard model, age, sex, tumor location, T and N stages, histologic differentiation, and adjuvant chemotherapy were independent prognostic factors for resected PDAC. After an exhaustive search and 10-fold cross validation, the best model was finally developed, which included all prognostic variables. The C-index, 1-year, 2-year, 3-year, and 5-year time-dependent AUCs were 0.628, 0.650, 0.665, 0.675, and 0.686, respectively. Conclusions: The survival prediction model for resected PDAC could provide quantitative survival probabilities with reliable performance. External validation studies with other nationwide databases are needed to evaluate the performance of this model.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Epidemiologia / Incidencia / Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Gut Liver Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Epidemiologia / Incidencia / Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Gut Liver Ano de publicação: 2021 Tipo de documento: Article